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Abstract
Bacterial superantigens (SAgs) are exotoxins produced mainly by Staphylococcus aureus and Streptococcus pyogenes that can
cause toxic shock syndrome (TSS). According to current paradigm, SAgs interact directly and simultaneously with T cell
receptor (TCR) on the T cell and MHC class II (MHC-II) on the antigen-presenting cell (APC), thereby circumventing
intracellular processing to trigger T cell activation. Dendritic cells (DCs) are professional APCs that coat nearly all body
surfaces and are the most probable candidate to interact with SAgs. We demonstrate that SAgs are taken up by mouse DCs
without triggering DC maturation. SAgs were found in intracellular acidic compartment of DCs as biologically active
molecules. Moreover, SAgs co-localized with EEA1, RAB-7 and LAMP-2, at different times, and were then recycled to the cell
membrane. DCs loaded with SAgs are capable of triggering in vitro lymphocyte proliferation and, injected into mice,
stimulate T cells bearing the proper TCR in draining lymph nodes. Transportation and trafficking of SAgs in DCs might
increase the local concentration of these exotoxins where they will produce the highest effect by promoting their encounter
with both MHC-II and TCR in lymph nodes, and may explain how just a few SAg molecules can induce the severe pathology
associated with TSS.
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Introduction
Bacterial superantigens (SAgs) comprise a large family of
exotoxins produced mainly by Staphylococcus aureus and Streptococcus
pyogenes [1]. SAgs produced by S. aureus include SEA through SER,
excluding F, and TSST-1, and constitute the major cause of food
poisoning in humans. These SAgs induce diarrhea, emesis, and
systemic intoxication, leading to a severe condition known as toxic
shock syndrome (TSS). This syndrome includes high fever of
sudden outbreak, rash, diarrhea and, in some cases, renal and lung
failure that may end in death. S. pyogenes SAgs including SPEA and
SSA, cause scarlet fever, pyrogenicity, and a fulminant illness
known as streptococcal TSS, which displays features similar to
staphylococcus TSS. SAgs are classified as Category B priority
agents by the Centers for Disease Control and Prevention because
of their potential use in bioterrorism and biological warfare.
The biological effects of SAgs rely on their capacity to induce
the massive release of inflammatory cytokines such as IL-2, INF-c,
and TNF-a. This cytokine storm has been shown to depend on the
interaction of the SAg with the T cell receptor (TCR) present on T
cells, and major histocompatibility complex class II molecules
(MHC-II) on antigen-presenting cells (APCs) [Reviewed in 2]. In
conventional antigen processing, antigens are incorporated by
APCs, processed into peptide fragments, and the fragments
presented to T cells bound to MHC-II molecules. T cells will
only respond if they recognize the MHC-II molecule and the
specific antigenic peptide being presented. By contrast, SAgs
stimulate T cells, as unprocessed intact proteins, by simultaneously
binding MHC-II and TCR.
The direct interaction of SAgs with TCR and MHC-II has been
demonstrated by several biophysical methods, including surface
plasmon resonance (SPR), calorimetry, and analytical ultracentri-
fugation [3–14], and by X-ray crystallography of binary [15–22]
and ternary [23] complexes. These structures revealed how SAgs
circumvent the normal mechanism for T cell activation by
peptide/MHC and how they stimulate T cells expressing TCR b
chains from a number of different families, resulting in polyclonal
T cell activation. Recently, the crystal structure of the ternary
complex between the staphylococcal superantigen SEH and its
human receptors MHC-II and TCR was obtained. Unlike the
conventional SAg engagement of the TCR Vb domain, SEH
predominantly interacts with the Va domain [24]. Collectively,
these studies support the current paradigm of direct and
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simultaneous interaction of SAgs with TCR on the T cell and with
MHC-II on the APC, thereby circumventing intracellular
processing to trigger T cell activation. However, an unexplored
issue is how SAgs reaches the site where APCs and T cells are in
close contact, namely lymphoid tissues, and where simultaneous
binding of TCR and MHC-II actually occurs.
Dendritic cells (DC) are professional APC located at mucosal
and epithelial surfaces where they perform a sentinel function
looking for foreign antigens. DCs actively take up antigens, process
them, and, following activation, initiate maturation and migration
to the lymph nodes where they activate T lymphocytes to trigger
the adaptive immune response [25]. DCs coat nearly 95% of
mucosal and skin surfaces, where many streptococcal and
staphylococcal infections occur, and, thus, they are the most
probable candidate to interact with SAgs. However, immature
DCs continuously take up antigens from their microenvironment,
which implies continuous cell membrane internalization. This
activity could represent a limitation to superantigenicity, since
SAgs could be internalized, as many other antigens, and not
remain on the cell surface to interact with TCR. In addition, it is
not clear what would happen to SAgs interacting with an
immature APC if they were incorporated, since such antigens
are normally processed into peptides, which would abrogate SAg
activity.
Several studies have analyzed the interaction of bacterial SAgs
with DCs. Incorporation by DCs of the streptococcal SAg SMEZ-
2, conjugated or not to OVA, was demonstrated by confocal
microscopy [26]. Human monocyte-derived DCs showed in-
creased expression of maturation markers after 48 h of incubation
with SEB [27]. Another study used a cocktail of SAgs (TSST-1,
SEE, SEA, SEC and SED) to induce migration of immature DCs,
which required CD4+ T cells [28]. Other studies have shown that
DC maturation by SAgs depends on the presence of T cells [29–
33]. Most of these studies have assumed that SAgs interact with
MHC-II on the cell membrane of DCs in the extracellular space.
However, they have not addressed whether SAgs are incorporated
by DCs in the same manner as conventional antigens, and, if so,
how SAgs escape antigen processing.
Here, we analyzed SAg interactions with mouse DCs and
demonstrated that: 1- DCs take up SAgs; 2- SAgs alone are not
able to trigger DC maturation; 3- SAg can be found in the
intracellular membrane system of DCs as biologically active
molecules; 4- SAgs are present in the acidic compartment and
remain active; 5- SAgs co-localize with EEA1, RAB-7 and LAMP-
2 at different times after incorporation; 6- SAgs are recycled to the
cell membrane of DCs as soon as 2 h after uptake; 7- DCs loaded
with SAgs are capable of triggering potent in vitro lymphocyte
proliferation; and 8- DCs pulsed with SAgs and injected into mice
stimulate T cells bearing the proper TCR b chain in draining
lymph nodes. Collectively, these results suggest that intracellular
trafficking of SAgs in DCs serves to increase the local concentra-
tion of SAgs and promote their encounter with both MHC-II on
APCs and TCR on T cells in lymph nodes. In addition, the
interaction of SAgs with DCs may explain how just a few SAg
molecules secreted by infecting bacteria can induce the severe
pathological effects associated with TSS and other SAg-mediated
disorders.
Results
SAgs are Efficiently Incorporated by DCs without
Inducing DC Maturation
In order to determine whether mouse DCs are able to
internalize SAgs, cells were incubated with FITC-labeled S. aureus
SEG and SEI, and S. pyogenes SSA, and immunolabeled with
CD11c-PE. Cells were analyzed by FACs in the presence of trypan
blue, and compared to non-pulsed DCs as control. Fig. 1A shows
that a high percentage of DCs internalized SEG-FITC after a
pulse in a dose-dependent manner, and that this process was
markedly reduced when the pulse was carried out at 4uC.
Unlabeled SEG was not able to inhibit the uptake of SEG-FITC
(result not shown), suggesting that a specific saturable receptor was
not involved. The phosphoinositide 3-kinase (PI3K) inhibitor
wortmannin (WT) and the ion exchange inhibitor 5-[N-ethyl-N-
isopropyl] amiloride (EIPA) were used to elucidate whether
macropinocytosis was responsible for SAg incorporation. Fig. 1B
shows a strong reduction of SEG-FITC internalization when the
pulse was performed in the presence of WT (71.0% of inhibition)
or EIPA (71.2%). The dot plot analysis of CD11c+ versus FITC+
cells for a concentration of SEG-FICT 50 mg/ml in the different
conditions is shown in Fig. S1 in File S1. Similar results were
obtained with SEI and SSA (data not shown). In addition, we
cultured DCs for longer time in the cold or in the presence of WT,
DMSO or EIPA with not changes in viability (results not shown).
Next, we analyzed whether SAgs are able to induce phenotypic
maturation of murine DCs. LPS and three SAgs (SEG, SEI and
SSA) were incubated with DCs and expression of CD80, CD86
and MHC-II was analyzed by cytometry after 24 h of incubation.
In contrast to LPS, SAgs did not induce any change in the
expression of MHC-II (Fig. 1C upper panel and Fig. 1D), CD80
(Fig. 1C lower panel and Fig. 1E), CD86 (Fig. S2 I in File S1)
and CD40 (Fig. S2 J in File S1). Percentage of positive cells is
shown in Fig. S2 D, E and F in File S1. However, when DCs
underwent maturation after treatment with LPS, their ability to
incorporate SAgs was lost (data not shown). Consistent with these
results, we found that endocytosis of OVA-FITC was inhibited in
LPS-treated DCs, as expected, but not impaired in SAg-treated
DCs (Fig. 1F). Together, these results indicate that macropino-
cytosis plays a major role in SAgs uptake by DCs and that SAgs do
not induce maturation of DCs. Since we did not find any
difference among the three SAgs analyzed, we conducted all
subsequent experiments with SEG, unless noted otherwise.
To evaluate the presence of SAgs in the intracellular
compartment, and to investigate whether these exotoxins resist
degradation, DCs were pulsed for 1 h with SEG as previously
described, washed, and cultured from 0 to 24 h. After incubation,
the endosome/lysosome fraction was isolated as described in
Materials and Methods. The endosome/lysosome fraction was
isolated and lysed by repeated cycles of freezing and thawing, and
exposed to syngeneic splenocytes to assess cell proliferation as a
biological method for detecting SAgs. SEG was effectively detected
in extracts carried out immediately after the pulse and also 2 h
later. However, extracts isolated at 4 and 24 h after pulsing
showed no signs of biologically active SEG (Fig. 1G). The absence
of SAg activity at 4 and 24 h could be attributed to both
degradation of the SAg, migration to other subcellular locations
such as the cytoplasm or cell membrane, or release into the
medium. To test for the presence of SAg on the cell membrane, we
carried out indirect immunolabeling of SEG with mouse anti-SEG
polyclonal antibodies at different time points. SEG could not be
detected on the cell membrane at 0 and 2 h after the pulse, which
is in agreement with the presence of the SAg in the endosomal/
lysosomal compartment. Surprisingly, SEG was detected on the
membrane 4 h after the pulse, coincident with the loss of detection
of SEG in the intracellular compartment (Fig. 1H). After 24 h, no
active SAg could be detected in the endosomal/lysosomal
compartment or on the cell membrane. These experiments show
that SAgs conserve their molecular architecture sufficiently to be
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Figure 1. SAg incorporation in DCs and cell activation markers. Bone marrow DCs were pulsed 1 h with SEG-FITC, washed, and
immunolabeled with anti CD11c-PE. (A) Percentage of DCs incorporating different concentration of SEG-FITC at 37uC and 4uC vs. non-pulsed DCs as
control. (B) Percentage of DCs showing inhibition of SEG-FITC internalization by wortmannin (WT) and 5-ethyl-N-isopropyl amiloride (EIPA) added at
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recognized by antibodies and stimulate syngeneic splenocytes
during their presence in endosomal/lysosomal compartments and
further exposure on the membrane.
Incorporated SAgs Traffic into Acidic Organelles
Since endosomal vesicles usually fuse with lysosomes that
contain enzymes at acid pH, laser scanning confocal microscopy
was used to investigate whether SAgs taken up by DCs were
located in acidic vesicles. DCs were pulsed for 1 h at 37uC with
SEG-FITC and LysoTracker Red, washed four times, and
cultured from 0 to 120 min. Cells were collected at different time
points, washed, and fixed. Confocal images were captured using a
PlanApo 606 Oil AN 1.40 immersion objective. Controls with
non-pulsed cells (autofluorescence) and cells pulsed at 4uC were
performed in parallel (data not shown). Fig. 2 shows that, after a
1 h pulse (time point 0), SEG was incorporated but hardly any
SAg co-localized with LysoTracker Red, which was inside acidic
organelles in the cytoplasm. However, 40 (not shown) to 60 min
after pulse, SEG co-localized preferentially with the LysoTracker
probe in a few large acidic organelles. The bright spots represent
increased LysoTracker staining and indicate regions of high
lysosomal activity. The label faded with time, but SEG could still
be observed in smaller acidic organelles distributed throughout the
cytoplasm at 120 min after pulse. By contrast, controls conducted
under similar conditions and time points with OVA and
LysoTracker showed that both co-localized in large organelles
after a 1 h pulse. However, 60 min after the 1 h pulse little or no
OVA could be detected, whereas LysoTracker was still visible
inside vesicles (Fig. 2).
SEG Co-localizes with EEA-1, LAMP-2 and RAB-7 in the
Lysosomal Compartment
Laser scanning confocal microscopy was also used to investigate
the location of SEG after DC uptake. For this purpose, we used
markers of early and late endosomes and lysosomes. DCs were
cultured in poly-L-Lys treated slides, pulsed for 1 h at 37uC with
SEG, washed, and cultured from 0–240 min. After washing and
fixing, cell immunolabeling was performed in the presence of
saponin for intracellular staining with rabbit polyclonal antibodies
against the early endocytic specific marker, EEA-1; the late
endosomal marker, Ras-related protein RAB-7; or the lysosomal-
associated membrane protein-2, LAMP-2; and mouse anti-SEG,
at 0, 20, 40, 60, 90, 120, 180 and 240 min end points. Normal
rabbit and mouse polyclonal antibodies were used as negative
control. Cells were then incubated with FITC-labeled anti-rabbit
and rhodamine A-labeled anti-mouse antibodies for analysis by
confocal microscopy. Fig. 3A shows that, immediately after the
pulse (0 min), SEG could be observed intracellularly in the
endomembrane compartment, co-localizing with EEA-1. Twenty
min later, SEG still co-localized with EEA1, but at 40 min after
the pulse, little or no EEA1 co-localized with SEG, although the
SAg remained in vesicles. Incubation times beyond 40 min after
the pulse showed no co-localization of EEA1 and SEG (data not
shown). Co-localization of SAg with the late endosomal-specific
RAB-7 GTPase started at 20 min when large and strongly stained
vesicles could be seen (Fig. 3B). Sixty min after the pulse, SEG co-
localized in vesicles with RAB-7 near the cell membrane; these
vesicles were not seen at 120 min, although traces of SEG were
still visible in intracellular compartments. When experiments were
conducted analyzing SEG co-localization with LAMP-2, co-
localization also began at 20 min after the 1 h pulse (Fig. 3C),
was intense at 60 min, and decayed at 90 min (not shown). At
120 min after the pulse, there was minimal co-localization of
LAMP-2 and SAg, which was absent at 240 min; however, in both
cases, the SAg could be found in clusters near the cell membrane.
Shorter pulses with SEG were tested, including pulses of 20 and
40 min instead of 60 min, and co-localization with the different
markers was studied at similar time points as previously. We
observed that shorter pulses only resulted in less SAg incorporated,
but did not affect co-localization patterns, times of progression, or
the length of time SEG remained inside the different kind of
vesicles (not shown).
SAg Co-localizes with MHC-II Molecules on the DC Cell
Surface and in Vesicles
Since the current paradigm holds that SAgs simultaneously bind
TCR on the T cells and MHC-II on the APCs, we next analyzed
whether SAg uptake was related to the presence of MHC-II on
DCs. We used a monoclonal antibody which recognizes both I-A
and I-E mouse MHC-II molecules. Fig. 4 shows that after a 1 h
pulse (time 0) SEG and MHC-II co-localized in the cytoplasm
close to the cell membrane. Sixty min later, both molecules co-
localized inside vesicles in the perinuclear area, and after 180 min,
both SEG and MHC-II were located in the periphery of the cell
membrane in a scattered pattern, despite also colocalize in vesicles
at that time. Since co-localization does not necessarily means that
both molecules traffic bound, we attempted to precipitate SEG
bound to MHC-II using polyclonal antibodies against either SEG
or MHC-II without success at any time (0–240 min) after DCs
were exposed for 1 h to the SAg. We also attempted to cross-link
both molecules at different times with the cross-linker bis(sulfo-
succinimidyl)suberate (BS3), but without success (not shown).
DCs are Able to Release Incorporated SAg
Since co-localization experiments showed that, after uptake and
inclusion in different intracellular vesicles, SAgs were directed to
the cell membrane as early as 1 h after pulse (Fig. 3), we next
analyzed whether DCs were able to release the SAg. DCs were
loaded with SEG for 1 h, carefully washed four times, and
incubated with fresh medium for 3 h. Supernatants were collected
and analyzed by SPR on a Biacore T100 biosensor. The SEG-
specific ligand TCR Vb8.2 was immobilized on a CM5 chip
surface. A surface with no protein immobilized was used as
control. Supernatants of cell pulsed with SEG, or not, were
injected over these surfaces for 60 sec. Fig. 5 shows strong binding
of SEG to its specific Vb8.2 ligand. After 3 h incubation, although
final concentrations of 100 nM and 50 mM, respectively, 15 min before SAg-FITC at 50 mg/ml. (C) Representative histograms of the phenotype of DCs
in the presence of SAgs. (D) Cell surface MHC-II molecules on DCs treated with SSA, SEG, SEI or LPS for 24 h, compared to non-treated basal control,
and expressed in MFI. (E) CD80 on SAgs- or LPS-treated DCs compared to non-treated. (F) Endocytosis of OVA-FITC by SAg or LPS pre-treated DCs. (G)
DCs were incubated for 1 h with SEG at 37uC or 4uC as control, washed, and cultured for additional periods from 0 to 24 h. At each endpoint, cells
were washed and disrupted in order to isolate the endosomal/lysosomal compartment. These fractions were incubated with mouse splenocytes to
assess proliferative activity by 3H-Thy incorporation in triplicate. The proliferation index (PI) was calculated as cpm/basal cpm. Basal represent the
proliferation of T cells stimulates by DCs incubated in the absence of SAg. (H) SEG-pulsed DCs cultured for additional periods of 0 to 24 h. At each
endpoint, cells were washed and immunolabeled with mouse anti-SEG polyclonal antibodies and anti-mouse-FITC, as second antibody to evaluate
the presence of SEG on the cell surface. Figures show a representative experiment of 3–5. *p,0.05, **p,0.01.
doi:10.1371/journal.pone.0066244.g001
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the SAg was released to the medium, DCs still contained SEG in
their vesicles (not shown). In order to further demonstrate that the
SPR results were due to specific binding of SEG, we neutralized
the supernatant with rabbit anti-SEG and passed the supernatant
over the CM-5 chip surfaces with or without Vb8.2. Fig. 5 shows
that the neutralized supernatant was unable to bind immobilized
Vb8.2. The inset shows an immunoblot in which SEG in the
supernatant was identified by specific rabbit antibodies.
DCs Pulsed with SEG Trigger Superantigen-Specific
Response in Splenocytes
To determine whether SAgs exposed on the DC cell membrane
are able to induce a superantigenic response, mixed culture with
splenocytes were carried out. DCs were pulsed with SEG as
previously described, and co-cultured for an additional period of
72 h with syngeneic splenocytes. 3H-Thy incorporation for DCs,
splenocytes, or DCs plus splenocytes showed significant differences
between proliferation induced by 37uC pulsed DCs vs. basal non-
pulsed DCs, while 4uC pulsed DCs showed no increment in
proliferation (Fig. 6A). 3H-Thy incorporation assays revealed that
DCs pulsed with different concentration of SEG efficiently
induced cell proliferation in a dose-dependent manner (Fig. 6B).
Splenocyte proliferation induced by pulsed DCs was significantly
reduced when SEG was added in the presence of WT (72614%
inhibition) or at 4uC (8268% inhibition) (Fig. 6C), which
demonstrates the requirement of SAg incorporation for eliciting
a proliferative response. To demonstrate that splenocyte prolifer-
ation was due to a superantigenic effect, we carried out
experiments with the addition of an SEG-specific rabbit polyclonal
antiserum to the co-cultures. The results showed that rabbit anti-
SEG abrogated splenocyte proliferation induced by pulsed DCs,
even at high antibody dilutions (161025) (Fig. 6D). Additionally,
to rule out any hypothetical impairment of cell function caused by
the antiserum, splenocytes were cultured with SEG (0.01 mg/ml)
or ConA (1 mg/ml), with or without anti-SEG. Antibodies
specifically blocked superantigenic activity, whereas proliferation
induced by the mitogen Con A was not blocked at any antiserum
dilution (Fig. 6E).
SEG-Pulsed DCs Specifically Stimulate Lymphocytes
Bearing Vb8.2 in vivo and in vitro
To further confirm that the observed proliferation corresponded
to the superantigenic effect of SEG, we analyzed populations of
lymphocytes bearing different Vb chains in mixed cultures. SEG
has been reported to stimulate the proliferation of mouse T cells
expressing Vb8.2, Vb7, and Vb9 [10,22]. We selected Vb8.2 and
Figure 2. After incorporation in DCs, SEG co-localize with LysoTracker in acidic organelles. DCs were cultured on poly-L-lysine treated
slides, pulsed 1 h at 37uC with 50 mg/ml SEG-FITC and 50 mM Lysotracker RED (Molecular Probes, Invitrogen), washed and cultured further for
different time periods (0–120 min). Fluorescently labeled cells were fixed with paraformaldehyde at 4uC, and cover slides mounted using anti-fade
mounting media (Vector Laboratories). Image capture was performed using a Nikon C1 confocal laser scanning microscope with a PlanApo 606Oil
AN1.40 lens. For detection of FITC a 490 nm laser was used. A 546-nm excitation wavelength and a 590-nm emission wavelength were used for
LysoTracker. Analysis by confocal microscope (60006) shows that SEG barely co-localized at acidic compartment at time point 0, but clearly co-
localized with LysoTracker at the 60 min time point and later. Cells pulsed with 50 mg/ml OVA-FITC for 1 h showed co-localization of OVA with
Lysotracker at time point 0, but 60 min later only LysoTracker remained inside the cell. Figure shows a representative experiment of 3.
doi:10.1371/journal.pone.0066244.g002
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Vb8.3 TCRs as representative of populations stimulated and not
stimulated by SEG, respectively. Mixed cultures were performed
as previously described. After 48 h of culture, cells were
immunolabeled with PE-conjugated anti-Vb8.2 or anti-Vb8.3
antibodies. FACS analysis revealed a significant increase in the
percentage of Vb8.2+1 bearing T cells vs. basal level, while Vb8.3+
T cells were similar to control (Fig. 7A). A reduction of the TCR
Vb8.3 cell population compared with basal levels is often observed
in superantigenic responses, and is probably due to an increase in
the percentages of other T cell populations.
We next analyzed whether stimulation of T cells bearing
Vb8.1+2 by SAg pulsed-DC could be reproduced in vivo. DCs
pulsed with SEG at 37uC and 4uC were intradermically injected
into the mice foot pad of BALB/c mice. After 48 h, mice were
sacrificed and their popliteal lymph nodes removed for analysis of
Vb8.2+1 and Vb8.3 T cell populations. FACS analysis showed a
significant increase of Vb8.2+ T cells in lymph nodes stimulated
with DCs pulsed at 37uC, while DCs pulsed at 4uC were unable to
stimulate Vb8.2+1+ T cells (Fig. 7B).
Discussion
Immature DCs use both macropinocytosis and receptor-
mediated endocytosis to internalize soluble antigens efficiently.
Usually, antigens are rapidly broken down following endocytosis.
However, DCs also have the capacity to store unprocessed
conventional antigens for long periods and to release them to the
cell surface or to the extracellular medium [34–37]. Our present
results indicate that DCs effectively take up SAgs, retain
unmodified SAgs in endosomes, and finally release them to the
extracellular medium. Fig. 7C shows a schematic diagram
depicting SAgs uptake and trafficking in DCs. We hypothesize
that this trafficking mechanism might promote the efficient
encounter of SAgs with both DCs and T cells in lymph nodes.
The current paradigm for T cell activation by SAgs proposes
direct and simultaneous interaction of SAg with TCR on the
surface of the T cell, and with MHC-II on the surface of the APC
[1,38]. The activation of both APC and T cell produces a cytokine
storm that can lead to TSS. However, little is known about the
sites where SAgs encounter their specific ligands and how they
Figure 3. After incorporation in DCs, SEG is located in vesicles
inside DCs and then is exposed on cell membrane. DCs were
cultured on poly-L-lysine treated slides, pulsed 1 h at 37uC with SEG,
washed, and cultured further for different time periods (0–240). Indirect
Immunolabeling of intracellular SEG and the organelle-specific markers
was conducted with mouse polyclonal serum to SEG concurrently with
polyclonal rabbit anti-EEA1, anti-RAB-7 or anti-LAMP-2, (Sigma Aldrich,
St. Louis, MO). Cells were then incubated with FITC-labeled anti-rabbit
and rodamine A-labeled anti-mouse for analysis by confocal microsco-
py. Image capture was performed using a Nikon C1 confocal laser
scanning microscope with a PlanApo 606Oil AN1.40 lens. For detection
of rhodamine, a 543 nm laser and 490 nm laser for FITC were used.
Controls of non-pulsed cells were performed in parallel. (A) Immediately
(0 min) and 20 min after the 1 h pulse, the location of SEG (red) was
exclusively intracellular and showed strong co-localization with EEA1
(green), which was lost at 40 min of culture. At this latter time, SEG was
still inside vesicles, but EEA1 was scattered throughout the cell
cytoplasm. (B) Co-localization of SEG with RAB-7 starts at 20 min after
1 h pulse with SAg. At 60 min, a portion of SEG could be seen in RAB-7+
small vesicles scattered throughout the cytoplasm and also concen-
trated in clusters near the cell membrane. One hundred and twenty min
after pulse, SEG was seen in RAB-7 negative vesicles. (C) Only 20 min
after the 1 h pulse, SEG could be detected in the lysosomal
compartment surrounded by LAMP-2). At 60 min, co-localization with
SEG was also apparent. However, at 120 min, there was only trace co-
localization of LAMP-2 and SEG, but clusters of SAg could be seen on
the cell membrane, which remained up to 240 min of culture. Figures
show a representative experiment of 4–5.
doi:10.1371/journal.pone.0066244.g003
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reach those sites. DCs are specialized APCs present in all tissues
which, after activation by antigens, have the ability to migrate to
the next lymph node where they encounter circulating T cells that
are looking for specific antigens to became effector T cells. The
idea of SAgs interacting with T cells in peripheral tissues or in the
blood, where they can only encounter a very limit number of T
cells, is unlikely, whereas the idea of SAgs reaching lymph nodes
through which every T cell will pass is more consistent with the
known ability of SAg to elicit powerful T cell activation. Thus,
lymph nodes would be the expected site for SAg to interact with
their cognate ligands and activate T cells bearing particular Vb
regions. In a natural infection with SAg-producing bacteria, the
draining lymph node of the infection site would be the most likely
encounter site; SAgs could reach it as soluble antigen in lymphatic
fluid. Here, we tested an alternative route for SAgs to encounter
their specific ligands.
Immature DCs have an extraordinary ability to sample the
surrounding environment by endocytosis. They use two main
mechanisms for antigen capture: macropinocytosis, which occurs
in a constitutive fashion in DCs and allows continuous internal-
ization of antigens present in the fluid phase, and receptor-
mediated endocytosis, which involves the internalization of
antigens and pathogens after clustering of specific receptors
[39,40]. We initially analyzed in vitro SAg uptake by DCs and
found that S. aureus SEG and SEI, as well as S. pyogenes SSA, were
efficiently incorporated in a dose-dependent manner. This process
was inhibited by WT and EIPA, an ion exchange inhibitor that
inhibits membrane ruffling, strongly suggesting that uptake is by
macropinocytosis [41]. Uptake of SEG, SEI or SSA does not
induce the maturation of DCs, which has also been recently
demonstrated for SEB and SEA [33]. Conversely, Muraille et al.
[30] found that intravenous injection of SEB or TSST-1 in mice
induces maturation of DCs in the spleen, but that this was a
consequence of in vivo T cell stimulation produced by the
simultaneous binding of the exotoxins to TCR and MHC-II.
Similarly, in vivo administration of SEA- increased the number of
plasmocytoid DCs in secondary lymphoid organs and induced
CD86 and CD40 expression, although that effect strictly required
the presence of IFN-c [31]. However, incubation of immature
DCs with SAg alone neither changed cellular morphology nor did
DCs became mobile [28]. Thus, we speculate that during the
course of infection by S. aureus or S. pyogenes, the maturation of DCs
and their migration to the lymph nodes would be induced by
components other than the SAgs themselves, including bacterially-
derived pathogen-associated molecular pattern (PAMPs) such as
lipoteichoic acid and peptidoglycans [42,43].
We next analyzed the fate of SAgs after DC uptake. We used
laser scanning confocal microscopy to examine the subcellular
Figure 4. SEG co-localizes with MHC-II at the cell membrane and in vesicles. DCs were cultured in poly-L-lysine treated slides, pulsed 1 h at
37uC with SEG-FITC, washed four times and cultured for different periods (0–240 min). Cells were then fixed with paraformaldehyde and
permeabilized with saponin for immunolabeling with a phycoerythrin-Cy5-labeled monoclonal antibody against mouse I-A and I-E MHC-II. A control
of non-pulsed cells was performed in parallel. Confocal images were captured using a PlanApo 606Oil AN1.40 lens. After 1 h pulse, SEG showed a
dispersed pattern, with some clusters, near the cell membrane. Strong staining of MHC-II was observed at a similar location. At 60 min, SEG co-
localized with MHC-II in vesicles. One hundred and eighty min later, clusters of MHC-II and SEG were observed, in addition to a scattered pattern for
both SEG and MHC-II close to the cell membrane. Figure shows a representative experiment of 5.
doi:10.1371/journal.pone.0066244.g004
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localization of SAgs after a 1 h pulse. SEG co-localized
preferentially with the LysoTracker probe in a few large acidic
organelles as soon as 60 min after the pulse, and later in multiple
small endosomal vesicles. EEA1 is a membrane-bound protein
component specific to the early endosome and is essential for
fusing early endocytic vesicles and for phagosomal maturation
[44]. SEG was found in vesicles identified by the EEA1 protein
from time points 0 to 40 min after the 1 h pulse. By contrast, a
mutant of the streptococcal superantigen SMEZ-2 conjugated with
OVA seemed to follow a different intracellular pathway, since it
remained in a EEA1-negative compartment at 10 and 30 min
after pulsing [26]. This effect cannot be attributed to conjugation
because OVA alone co-localized with EEA1 at both time points.
Further investigation is needed to determine whether segregation
to a different intracellular compartment is a unique property of the
SMEZ-2-OVA conjugate, or a particularity of some SAgs.
RAB-7 is a key regulator in endo-lysosomal trafficking which
governs early-to-late endosomal maturation, microtubule directed
endosomal migration and positioning, and endosome-lysosome
transport [45–48]. Co-localization of SEG with RAB-7 began
20 min after a 1 h pulse and persisted for at least 40 more min.
Similarly, SEG co-localized with LAMP-2, a marker protein for
lysosomes, from 20 min after a 1 h pulse until at least 100 min.
Strikingly, 60 min after a 1 h pulse, SEG co-localized with RAG-7
or LAMP-2 near the DC cell membrane (Fig. 3C and D).
LAMP-2 has been described as mainly associated with lysosomes,
but can also shuttle between early endocytic compartments and
the plasma membrane [49], which may explain co-localization in
places where the SAg will be during trafficking in DCs.
We also analyzed whether SAgs maintain superantigenicity after
DC incorporation. We found that SEG in the acidic environment
of the endosomal/lysosomal compartment (Fig. 2 and Fig. 3),
SEG in the membrane 2 h later, as well as SEG released into the
medium after 3 h (Fig. 5), was biologically active. Moreover, the
SAg retained enough structure to allow recognition by polyclonal
mouse and rabbit antisera during the entire process of uptake,
inclusion in diverse vesicles, and exposure on the membrane, in
addition to being able to stimulate specific T cells bearing
particular TCRs. These results strongly suggest that SAgs traffic
through DCs in intact form. This is not surprising, since SAgs are
known to be very stable and highly resistance to proteases, and can
resist temperatures of 60uC or higher, as well as pH extremes of
2.5 to 11 [50,51].
Since SAgs bind MHC-II, we analyzed whether SAg uptake by
DCs was related to the presence of MHC-II on the cell membrane.
Even though we used immature DCs which do not have high
expression of MHC-II, SEG co-localized with MHC-II near the
cell membrane 1 h after pulsing (Fig. 4). Sixty min later, both
molecules were inside vesicles and 180 min after the pulse, both
molecules could be seen near the cell membrane, which is in
agreement with the intracellular trafficking of SEG reported here.
However, attempts to precipitate SEG bound to MHC-II were
unsuccessful at any time after DCs were exposed to the SAg, using
polyclonal antibodies against either SEG or MHC-II. We also
attempted to cross-link both molecules at different times (0–
240 min after a 1 h pulse of SAg) with the cross-linker
bis(sulfosuccinimidyl)suberate (BS3) that we used previously to
determine the stoichiometry of the Ly49A-H-2Dd complex [52],
but without success (not shown). The failure to demonstrate
formation of a SEG-MHC-II complex in murine DCs could be
due to lack of contact with MHC-II during entrance and
trafficking of the SAg, or to a fast dissociation rates (short half
life) of the SEG-MHC-II interaction. Although the affinity and
kinetics of SEG binding to murine MHC-II have not been
measured, we previously determined by analytical ultracentrifu-
gation that SEG binds the human MHC-II molecule HLA-DR1
Figure 5. Analysis of SAg uptake by DCs and release into the medium by SPR. DCs were incubated in the presence, or absence, of 100 ug/
mL SEG for 1 h, washed four times, and cultured in fresh medium for 3 h (SNSEG). Supernatant SNSEG diluted two-fold in fresh medium, or DC culture
medium (CM) were injected over immobilized TCR Vb8.2 and responses recorded as a function of time for 60 sec (30–90 sec), and then buffer was
injected for dissociation. In addition, SNSEG diluted two-fold in fresh medium were neutralized with mouse anti-SEG (SNSEG+Ab) and injected over
immobilized TCR Vb8.2. Inset: Immunoblot of supernatant from DCs incubated in the presence (SNSEG) or absence (CM) of SEG. MWM: molecular
weight markers. Figure shows a representative experiment of 3.
doi:10.1371/journal.pone.0066244.g005
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Figure 6. DCs induce superantigenic response after SEG uptake. DCs were pulsed 1 h at 37uC or 4uC with SEG, washed, and co-cultured with
isogenic splenocytes in triplicate; controls of DCs with no addition of splenocytes were conducted in parallel. (A) 3H-Thy incorporation for DCs,
splenocytes, and DCs plus splenocytes. (B) DCs were pulsed with different concentrations of SEG for a dose response curve, and co-cultured with
splenocytes in triplicates. (C) Splenocyte proliferation induced by SEG-pulsed DCs and SEG-pulsed DCs in the presence of Wortmannin, performed in
triplicates. (D) Rabbit anti-SEG serum was added to the cultures of pulsed DCs and splenocytes to specifically block SEG function. (E) Splenocytes
were cultured in the presence of 0.01 mg/ml SEG or 1 mg/ml ConA, with the addition, or not, of different dilutions of rabbit anti-SEG serum. One
representative experiment is shown of 3 to 5 experiments. **p,0.01.
doi:10.1371/journal.pone.0066244.g006
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with relatively low affinity (KD= 32 mM) [12]. In addition, all SAgs
examined to date display higher affinity for human than murine
MHC-II molecules [53].
We next analyzed whether the incorporated SAg, was able to
stimulate T cell proliferation. In vitro experiments showed that
SEG-pulsed DCs could stimulate splenocytes from syngeneic mice
expressing Vb8.2 TCRs. In vivo experiment gave similar results
when SEG-pulsed DCs were introduced into the foot pad and the
draining lymph node was analyzed for Vb8.2 T cell proliferation.
Manipulation of DCs after the SAg pulse or generation of
endogenous danger-associated molecular patterns (DAMPS)
caused by needle injury may explain the migration to the lymph
node in the absence of a maturation stimulus. In addition to
MHC-II and TCR, recent data strongly suggest that other
bacterial and host components play an important role in
mediating SAg effects. Thus, peptidoglycan-embedded molecules
interacting with Toll-like receptor 2 have been shown to induce
interleukin-10 production and apoptosis of APCs, thus downreg-
ulating T cell activation and preventing SAg-induced TSS [54]. In
addition, it has been demonstrated that the principal co-
stimulatory receptor CD28, constitutively present on T cells, is a
third SAgs receptor that is essential for induction of TSS [55,56].
Recently, APCs have been shown to use distinct endocytosis
mechanisms to simultaneously introduce soluble antigen into
Figure 7. After SEG uptake, DCs stimulate lymphocytes bearing Vb8.2 TCR. (A) DCs were pulsed 1 h at 37uC with SEG, washed, and co-
cultured with isogenic splenocytes. FACS analysis of T cell populations was conducted with PE-conjugated anti-Vb8.2+1 TCR and PE-conjugated anti-
Vb8.3 TCR monoclonal antibodies (BD Pharmingen). A control of non-pulsed DCs and splenocytes was conducted in parallel. (B) DCs pulsed at 37uC
or 4uC with 50 mg/ml SEG were injected intradermically into BALB/c mice foot pads. Control animals were injected with non-pulsed DCs in parallel.
FACs analysis with anti-Vb8.2+1 and anti-Vb8.3 was conducted on cells recovered from popliteal lymph nodes after 48 h. One representative
experiment is shown of 3. *p,0.05 and ** p,0.01. (C) Schematic diagram depicting SAgs uptake and trafficking in DCs. After incorporation
by macropinocytosis, SAgs can be located in early and late endosomes and lysosomes, as biologically active molecules, and then are recycled to the
cell membrane. After trafficking, SAgs are capable of stimulate T cells bearing the proper TCR, triggering lymphocyte proliferation.
doi:10.1371/journal.pone.0066244.g007
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separate intracellular compartments for degradation into peptides
and loading into MHC-I or MHC-II molecules for presentation to
CD8+ or CD4+ T cells, respectively [57]. Here we have shown that
SAgs escape and are released from DCs unharmed. How SAgs are
diverted from that fate and whether it is a property of the SAg or a
particular uptake mechanism of DCs remains to be clarified. In
this regard, Le Roux et al. [58] found that immature DCs are able
to store unprocessed antigens and release them in the lymph node
to be taken up by B cells. Based on our results, the uptake of SAgs
and their secretion in a form able to stimulate specific T cells may
represent a particular case of a more general mechanism for
transporting and presenting antigens in native form to T and B
cells in lymph nodes.
Materials and Methods
Ethics Statement
All procedures requiring animals were performed in agreement
with institutional guidelines and were approved by Review Board
of Ethics of IDEHU, CONICET, and conducted in accordance
with the guidelines established by the National Research Council
of Argentina.
Superantigens
Streptococcal SSA and staphylococcal SEI and SEG were
produced and purified as previously described [59,10]. Briefly,
proteins cloned in pET-26b were expressed in Escherichia coli BL21
cells and purified by Ni2+-NTA column chromatography, followed
by S-200 molecular exclusion. Proteins were treated with agarose-
polymixin B (Sigma Aldrich, St. Louis, MO) to remove LPS traces
and absence of LPS was assessed by Limulus test. The SAgs SEG,
SEI and SSA were labeled with FITC for endocytosis assays in
conjugation buffer (50 mM Na2CO3/NaHCO3 pH 9, 150 mM
NaCl) and free dye was removed using a G25 molecular exclusion
column. The F/P ratio was estimated by measuring Abs490 and
Abs260. F/P ranged between 2.6 and 3.2, and biological activity
was corroborated by spleen cell proliferation measured by 3H-Thy
incorporation at 72 h.
Polyclonal Antibodies to SEG
Polyclonal serum anti-SEG was obtained by immunizing mice
and rabbits with purified protein and Freunds adjuvant as
previously described [10].
Mice and Culture Conditions
Experiments were conducted using 8–12 week old male BALB/
c mice. They were housed 4–6 per cage and kept under standard
conditions. Unless otherwise specified, cell cultures and incuba-
tions were maintained at 37uC in a humidified atmosphere with a
5% CO2 atmosphere, using complete medium composed of RPMI
1640 supplemented with 10% heat-inactivated fetal bovine serum
(Gibco-BRL Life Technologies, Grand Island, NY), 2 mM L-
glutamine, 1 mM pyruvate, 100 U/ml penicillin, and 100 mg/ml
streptomycin.
Dendritic Cells
DCs were obtained from the bone marrow of BALB/c mice as
previously described [60–62], with minor modifications. Briefly,
femora and tibiae from mice were removed and stripped of
muscles and tendons; both ends were cut and bone marrow was
flushed with RPMI 1640 medium using a 21-gauge needle and
syringe. Cell clusters were dissociated by repeated pipetting and
0.45 M ammonium chloride was added for red cell lysis. After
washing the cell suspension once in RPMI 1640, cells were
resuspended in complete medium and cultured at a concentration
of 16106 cells/ml for 7 days in complete medium supplemented
with 20% conditioned medium from a GM-CSF producing cell
line (J558L myeloma cell line transfected with GM-CSF cDNA)
[63]. Cultures were fed at day 3 and 5 as follows: after gently
removing 75% of the medium, cells were centrifuged 10 min at
600 xg, the pellet was resuspended in fresh medium with GM-
CSF, and the cell suspension was returned to the dish. At day 7,
cells were evaluated for expression of CD11c and MHC-II by flow
cytometry, yielding 70–83% of cells positive for both markers. Cell
viability was also estimated by trypan blue exclusion to be .95%
in all experiments.
SAg-FITC Endocytosis
DCs were incubated at 16106 cells/0.2 ml in complete
medium, and SAgs-FITC were immediately added to final
concentrations of 50, 25, 10, 5 or 1 mg/ml SEG-FITC for 1 h at
37uC and at 4uC under 5% CO2. Then, cells were washed 4 times
in cold PBS, and analyzed by FACS, with the addition of trypan
blue at a final concentration of 200 mg/ml for quenching of
external fluorescence [64,65]. This concentration was determined
as the most efficient in previous experiments in which DCs were
stained with FITC-mAb directed to cell surface CD11c, as
described [66]. In order to determine the mechanism involved in
SEG uptake, and in a separate set of experiments, the
macropinocytosis inhibitors wortmannin (WT) and 5-(N-ethyl-N-
isopropyl) amiloride (EIPA) were added at final concentrations of
100 nM and 50 mM, respectively, 15 min before SAg-FITC at
50 mg/ml. A control with DMSO was performed, and cells were
analyzed by FACS as previously described.
Fenotipic Assay and OVA-FITC Endocytosis
DCs (16106 cells/ml) were incubated with 100 mg/ml of SSA,
SEG and SEI or 1 mg/ml of E. coli LPS (Sigma Aldrich, St. Louis,
MO) for 24 h at 37uC in complete medium. MHC-II, CD80 and
CD86 were measured by FACS and compared to basal expression
in DCs incubated without SAg. Isotype controls were performed.
For the OVA-FITC endocytosis assay, DCs were incubated with
SAgs or LPS as previously indicated, washed and incubated with
100 mg/ml of OVA-FITC (obtained as described above for SAgs-
OVA) for 3 h at 37uC. A control with OVA-FITC at 4uC
(background control) was performed.
Flow Cytometry
We examined DC fenotype by direct immunofluorescence
staining using FITC-labeled mAbs to I-Ad (MHC-II) or CD11c
and phycoerythrin-labeled antibodies to CD11c, I-Ad, CD40,
CD80 or CD86 (BD PharMingen, San Diego, CA). Stained cells
were analyzed by flow cytometry in a PASS III flow cytometer
(Partec, Go¨rlitz, Germany). Twenty thousand events were
acquired for each sample and data analysis was performed using
the WinMDI software program. Results were expressed as
percentage of positive cells or MFI as appropriate.
Presence of SEG in the Endosomal/Lysosomal Fraction
and on Cell Membrane
To evaluate the presence of SAgs in the intracellular
compartment, DCs were incubated for 1 h with SEG at 37uC or
4uC as control, washed, and cultured for additional periods from 0
to 24 h. At each endpoint, cells were washed and disrupted in
order to isolate the endosomal/lysosomal compartment as
previously described [67] with slight modifications. Briefly, 106
cells were lysed with hypotonic solution 20 mM Hepes, 0.5 mM
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EDTA, 0.25 M sucrose and 0.1% BSA, plus mechanical
disaggregation by 20 successive passing through a 27 G1/2
syringe. Lysates were then centrifuged 6 min at 1506g, and
supernatant recovered for an additional spin at 130006g for
10 min. Pellet containing endosome/lisosome fraction was kept at
220uC until proliferation assays were performed. Then, the
endosome/lysosome fraction was disrupted by repeated cycles of
freezing and thawing, resuspended in 0.3 ml of complete medium,
and exposed to syngeneic splenocytes in triplicate to assess cell
proliferation activity by 3H-Thy incorporation as a biological
method to detect SAgs. The proliferation index (PI) was calculated
as cpm/basal cpm. To analyze the presence of SAg on the cell
membrane, indirect immunolabeling was carried out. SEG-pulsed
DCs cultured as indicated before, were washed and cultured to
each endpoint. Indirect immunolabeling was carried out using
mouse polyclonal anti-SEG antibodies and anti mouse-FITC, as
second antibody; and cells were analyzed by FACS.
Co-localization Assays
Co-localization assays between SEG and different vesicle
markers (EEA1, RAB-7 and LAMP-2), were performed as follows.
DCs were attached to slides previously treated with poly-L-lysine
(0.01%) and cultured with 50 mg/ml of SEG for 1 h. Then, cells
were washed four times with RPMI 1640 to remove non-
internalized SAg. Afterwards, complete medium was added to
the slides and cells cultured further in order to allow them to
evolve for different periods of time: 0, 20, 40, 60, 90, 120, 180 and
240 min. Controls of DCs without SEG were performed at every
end point. When these different periods were concluded, cells were
washed twice with PBS and fixed with 2% paraformaldehyde at
4uC. The cells were then washed with PBS, blocked with 0.01%
glycine for 1 h, and permeabilized with 0.1% saponin for 10 min
for immunofluorescent labeling. Incubation for 1 h at room
temperature with the primary mouse polyclonal serum to SEG
concurrently with polyclonal rabbit anti-EEA1, anti-Rab7, anti-
Lamp2, (Sigma Aldrich, St. Louis, MO) was followed by 1 h
incubation with secondary antibodies, FITC-conjugated anti-
rabbit, and rhodamin-conjugated anti-mouse (Jackson ImmunoR-
esearch). Fluorescently labeled cells were fixed with paraformal-
dehyde at 4uC, and cover slides mounted using anti-fade mounting
media (Vector Laboratories). For co-localization of SEG with
acidic organelles, DCs were cultured in poly-L-lysine treated
slides, pulsed 1 h at 37uC with 50 mg/ml SEG-FITC or OVA-
FITC and 50 mM Lysotracker RED (Molecular Probes, Invitro-
gen), washed and cultured further for different time periods (0–
240 min). For SEG and MHC-II co-localization DCs were pulsed
with SEG-FITC, washed, and cultured for different periods as
described above. Cells were then fixed with paraformaldehyde and
permeabilized with saponin for immunolabeling with phycoery-
thrin-Cy5-labeled mAb against mouse I-A and I-E MHC-II. A
control with non-pulsed cells was performed in parallel. Image
capture was performed using a Nikon C1 confocal laser scanning
microscope with a PlanApo 606Oil AN1.40 lens. For detection of
rhodamine, a 543 nm laser and 490 nm laser for FITC were used.
A 546-nm excitation wavelength and a 590-nm emission
wavelength were used for LysoTracker.
Mixed Cultures
In order to determine the capacity of DCs pulsed with SEG to
induce superantigenic responses, DCs were co-cultured with
murine splenocytes for assessing total proliferation and stimulation
of SEG-specific Vb8.2+1 TCR bearing cells. DCs were pulsed 1 h
with 50, 25, 10, 5 or 1 mg/ml SEG at 37uC, washed four times,
counted in a Neubauer chamber and cell viability evaluated by
trypan blue exclusion. Cells were added to round bottom 96 well
plates in 0.2 ml of complete medium, at a responder cell-to-pulsed
DCs ratio of 10:1. Controls with non-pulsed DCs and cells pulsed
at 4uC were also performed. Cultures were conducted at 37uC
under CO2 for 72 h, and 1 mCi
3H-Thy was added for the last
16 h of culture to assess total proliferation. Cells were collected on
glass fiber paper and cpm determined by liquid scintillation
counting. Assays were conducted in triplicate, being shown a
representative of three experiments. Additional assays were
conducted in the presence of polyclonal rabbit anti-SEG, with
parallel controls using ConA in the presence of similar concen-
trations of antibodies, to ensure that the splenocyte proliferation
capacity was not abrogated. Proliferation of T cell populations
bearing specific Vb chains was evaluated as follows. Splenocytes
and DCs pulsed 1 h with 50 mg/ml SEG at 37uC were co-cultured
as previously described, harvested at 48 h, and direct immunola-
beling performed separately with PE-conjugated anti-Vb8.2+1
TCR and PE-conjugated anti-Vb8.3 TCR (BD Pharmingen).
Cells were evaluated by FACS to determine the percentage of
blasts bearing each TCR, and compared with control. An
additional control of blasts obtained from splenocytes stimulated
with 1 mg/ml of the mitogen concanavalin A (ConA) was
performed.
In vivo Assays
DCs pulsed with 50 mg/ml SEG were introduced by intrader-
mic injection into the foot pad of BALB/c mice. The left hind limb
foot pad was sterilized with alcohol and slowly injected with 25 ml
of cell suspension containing 0.26106 cells. Control animals were
injected with non-pulsed DCs in parallel. After 48 h, mice were
sacrificed by cervical dislocation, and their popliteal lymph nodes
removed. Afterwards, single cell suspensions were obtained from
each node by mechanical dislodging. Cells were immunolabeled
separately with PE-conjugated anti-Vb8.2+1 TCR and PE-
conjugated anti-Vb8.3 TCR, and the percentage of each
population evaluated by FACS.
Analysis of SAg Taken Up by DCs and Released to the
Medium
DCs were incubated in the presence, or absence, of 100 mg/mL
SEG for 1 h, washed four times and cultured in complete medium
for 3 h. After that, cells were centrifuged and supernatants (SNs)
diluted two-fold in fresh medium. Diluted SNs were passed over an
immobilized TCR Vb8.2 on a CM5 sensor chip and data
recorded as a function of time by SPR analysis using a Biacore
T100 instrument [4,12]. As a control, diluted SNs were treated
with an anti-SEG antiserum prior to injection over immobilized
TCR Vb8.2. In addition, immunoblotting was performed with
SNs from DCs incubated in the presence or absence of SEG and
revealed with rabbit anti-SEG polyclonal antibodies as previously
described [10].
Statistical Analysis
One-way ANOVA tests were performed to determine the
significance of differences between means, and p,0.05 was taken
as indicating statistical significance. In 3H-Thy incorporation
assays, the proliferation index was compared with 2, and statistical
significance was evaluated using p,0.05 in one sample test.
Supporting Information
File S1 Contains: Figure S1. Supplementary figure to
Figure 1 A and B. SAg incorporation in DCs. (A) DC
CD11c-PE isotype control; (B) CD11c expression and SEG
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incorporation in DC cultured at 37uC without SEG-FITC, and (C)
with 50 mg/ml of SEG-FITC. Percentage of DC incorporating
50 mg/ml SEG-FITC in the presence of (D) WT, (E) EIPA or (F)
at 4uC. Figure S2. Supplementary figures to Figure 1D, E
and F. SAg incorporation in DCs and cell activation
markers. Bone marrow DCs were pulsed 1 h with SEG-FITC,
washed, and immunolabeled with anti CD11c-FITC. (D) Cell
surface MHC-II molecules on DCs treated with SSA, SEG, SEI or
LPS for 24 h, compared to non-treated basal control, and
expressed as percentage of positive cells. (E) CD80 on SAgs- or
LPS-treated DCs compared to non-treated. (F) Endocytosis of
OVA-FITC by SAg or LPS pre-treated DCs. (I) CD86 on SAgs-
or LPS-treated DCs compared to non-treated. (J) CD40 on SAgs-
or LPS-treated DCs compared to non-treated. Figures show a
representative experiment of 3–5. *p,0.05, **p,0.01. Figure S3.
DCs re-expose SEG on plasma membrane. DCs were
pulsed with SEG for 1 h, cultured further for the indicated times
(0–240 min), and incubated with anti-SEG polyclonal antibodies
and specific FITC conjugated antibodies without fixation and
permeabilization treatment. The presence of SEG at the DC
plasma membrane after 3 h confirms that the SAg was re-exposed
on the cell membrane.
(DOCX)
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